Thrombolysis in acute ischaemic stroke: An update

Therapeutic Advances in Chronic Disease

Volumn 2, Issue 2, 2011, Pages 119-131

  Zaheer, Zahid ^a   Robinson, Thompson ^b   Mistri, Amit K ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

acute stroke; ischaemic stroke; thrombolysis; update

Indexed keywords

ALTEPLASE; HEPARIN; PLACEBO; PROUROKINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AGE; ARTERY OCCLUSION; BASILAR ARTERY OBSTRUCTION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY INJURY; CEREBRAL SINUS THROMBOSIS; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; ISCHEMIC PENUMBRA; MENSTRUATION; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; RECANALIZATION; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TREATMENT CONTRAINDICATION;

EID: 79960058709     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622310394032     Document Type: Review

References (49)

1. Astrup J. Siesjo B.K. Symon L. (1981) Thresholds in cerebral ischemia – the ischemic penumbra. Stroke 12: 723–725.
2. Audebert H.J. Kukla C. Vatankhah B. Gotzler B. Schenkel J. Hofer S. et al (2006) Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centres: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 37: 1822–1827.
3. Barber P.A. Demchuk A.M. Zhang J. Buchan A.M. for the ASPECTS Study Group. (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome in hyperacute stroke before thrombolytic therapy. Lancet 355: 1670–1674.
4. Berger C. Fiorelli M. Steiner T. Schäbitz W.R. Bozzao L. Bluhmki E. et al (2001) Hemorrhagic transformation of ischemic brain tissue. Asymptomatic or symptomatic? Stroke 32: 1330–1335.
5. Bravo Y. Martí-Fàbregas J. Cocho D. Rodríguez-Yáñez M. Castellanos M. Pérez de la Ossa N. et al (2008) Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis. Cerebrovas Dis 26: 126–133.
6. Breuer L. Schellinger P.D. Huttner H.B. Halwachs R. Engelhorn T. Doerfler A. et al (2010) Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: Initial single-centre experience. Int J Stroke 5: 68–73.
7. Castellanos M. Sobrino T. Millan M. Garcia M. Arenillas J. Nombela F. et al (2007) serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke. A multicenter confirmatory study. Stroke 38: 1855–1859.
8. Ciccone A. Valvassori L. Gasparotti R. Scomazzoni F. Ballabio E. Sterzi R. (2007) Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 38: 2191–2195.
9. Davis S.M. Donnan G.A. Parsons M.W. Levi C. Butcher K.S. Peeters A. et al for the EPITHET investigators. (2008) Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomized trial. Lancet Neurol 7: 299–309.
10. de Koninck P.L.J. Pijnenborg J.M.A. van Zutphen S.W. Arnoldus E.P.J. (2008) Postpartum stroke, a diagnostic challenge. Am J Emerg Med 26: 843.e3–843.e4.
11. Demchuk A.M. Hill M.D. Barber P.A. Silver B. Patel S.C. Levine S.R. for the NINDS rt-PA Stroke Study Group, NIH. (2005) Importance of early ischemic computed tomography changes using ASPECTS in NINDS rt-PA stroke study. Stroke 36: 2110–2115.
12. de Witte T. Cross C.J. III Moran P.T. Akins E. (1998) Collateral circulation and outcome after basilar artery thrombolysis. Am J Neuroradiol 19: 1557–1563.
13. Dorado L. Millán M. de la Ossa N.P. Guerrero C. Gomis M. López-Cancio E. et al (2009) Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischemic stroke after intravenous thrombolysis. Stroke 40: e163–e163.
14. Engelter S.T. Bonati L.H. Lyrer P.A. (2006) Intravenous thrombolysis in stroke patients of ≥80 versus <80 years of age–a systematic review across cohort studies. Age Ageing 35: 572–580.
15. European Stroke Organisation. (2008) ESO Guidelines for the Management of Ischaemic Stroke, Basel: European Stroke Organisation.
16. Furlan A. Higashida R. Wechsler L. Gent M. Rowley H. Kase C. et al (1999) Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study. A randomized controlled trial. JAMA 282: 2003–2011.
17. Furlan A.J. Eyding D. Albers G.W. Al-Rawi Y. Lees K.R. Rowley H.A. et al (2006) Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37: 1227–1231.
18. Gladstone D.J. Rodan L.H. Sahlas D.J. Lee L. Murray B.J. Ween J.E. et al (2009) A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke 40: 3841–3844.
19. Hacke W. Donnan G. Fieschi C. Kaste M. von Kummer R. Broderick J.P. et al (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768–774.
20. Hacke W. Albers G. Al-Rawi Y. Bogousslavsky J. Davalos A. Eliasziw M. (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: 66–73.
21. Hacke W. Kaste M. Bluhmki E. Brozmann M. Dávalos A. Guidetti G. et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317–1329.
22. Hacke W. Furlan A.J. Al-Rawi Y. Davalos A. Fiebach J.B. Gruber F. (2009) Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomized, double-blind, placebo-controlled study. Lancet Neurol 8: 141–150.
23. Heiss W.D. Kracht L.W. Thiel A. Grond M. Pawlik G. (2001) Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 124: 20–29.
24. Kang D.W. Chalela J.A. Dunn W. Warach S. (2005) MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 36: 1939–1943.
25. Kucinski T. Koch C. Eckert B. Becker V. Krömer H. Heesen C. et al (2003) Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 45: 11–18.
26. Lees K.R. Bluhmki E. von Kummer R. Brott T.G. Toni D. Grotta J.C. et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375: 1695–1703.
27. Leonhardt G. Gaul C. Nietsch H.H. Buerke M. Schleussner E. (2006) Thrombolytic therapy in pregnancy. J Thromb Thrombol 21: 271–276.
28. Lindsberg P.J. Mattle H.P. (2006) Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 37: 922–928.
29. Micieli G. Marcheselli S. Tosi P.A. (2009) Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vascular Health Risk Manag 5: 397–409.
30. Molina C.A. Saver J.L. (2005) Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 36: 2311–2320.
31. Murugappan A. Coplin W.M. Al-Sadat A.N. McAllen K.J. Schwamm L.H. Wechsler L.R. et al (2006) Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 66: 768–770.
32. National Audit Office. (2005) Reducing Brain Damage: Faster Access to Better Stroke Care, London: NAO.
33. National Institute of Health and Clinical Excellence (2007) Technology Appraisal Guidance 122, London: NICE.
34. National Institute of Neurological Disorders and Stroke (NINDS) Study Group. (1995) rt-PA Stroke Trial. N Engl J Med 333: 1581–1587.
35. National Stroke Foundation. (2010) Clinical Guidelines for Stroke Management, Melbourne: National Stroke Foundation.
36. Parsons M.W. Miteff F. Bateman G.A. Spratt N. Loiselle A. Attia J. et al (2009) Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology 72: 915–921.
37. Price C.I. Clement F. Gray J. Donaldson C. Ford G.A. (2009) Systematic review of stroke thrombolysis service configuration. Expert Rev Neurotherap 9: 211–213.
38. Royal College of Physicians of London (Intercollegiate Stroke Working Party). (2010) National Sentinel Stroke Audit Organisational Audit 2010. Available at: http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/stroke/Documents/2010-Stroke-Public-Report.pdf (accessed 6 December 2010).
39. Royal College of Physicians of London (Intercollegiate Stroke Working Party). (2009) National Sentinel Stroke Audit Phase II (clinical audit) 2008. Available at: http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/stroke/Documents/stroke-audit-report-2008.pdf (accessed 6 December 2010).
40. Reeves M.J. Arora S. Broderick J.P. Frankel M. Heinrich J.P. Hickenbottom S. et al (2005) Acute stroke care in the US: results from the 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36: 1232–1240.
41. Rha J.-H. Saver L.J. (2006) The impact of recanalization on ischemic stroke outcome. A meta-analysis. Stroke 38: 967–973.
42. Solling C. Ashkanian M. Hjort N. Gyldensted C. Andersen G. Ostergaard L. (2009) Feasibility and logistics of MRI before thrombolytic treatment. Acta Neurol Scand 120: 143–149.
43. Sudlow C.L.M. Warlow C.P. (1997) Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 28: 491–499.
44. Tsivgoulis G. Eggers J. Ribo M. Perren F. Saqqur M. Rubiera M. (2010) Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 41: 280–287.
45. Wahlgren N. Ahmed N. Davalos A. Hacke W. Millán M. Muir K. et al (2008) Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372: 1303–1309.
46. Wardlaw J.M. Murray V. Berge E. del Zoppo G.J. (2009) Thrombolysis for acute ischaemic stroke. Cochrane Database Systematic Rev 4; CD000213.
47. Wein T.H. Hickenbottom S.L. Morgenstern L.B. Demchuk A.M. Grotta J.C. (2002) Safety of tissue plasminogen activator for acute stroke in menstruating women. Stroke 33: 2506–2508.
48. Weir N.U. Buchan A.M. (2005) A study of the workload and effectiveness of a comprehensive acute stroke service. J Neurol Neurosurg Psych 76: 863–865.
49. Yue X. Xi G. Zhou Z. Xu G. Liu X. (2010) Combined intraarterial and intravenous thrombolysis for severe cerebral venous sinus thrombosis. J Thromb Thrombol 29: 361–367.